UBS Group’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-1
Closed -$1K – 8767
2015
Q1
$1K Sell
1
-23
-96% -$26.9K ﹤0.01% 8590
2014
Q4
$27K Buy
+24
New +$24.6K ﹤0.01% 7228

Other funds holding RMTI

UBS Group's RMTI Position: Q3 2026 in Review

UBS Group increased its Rockwell Medical (RMTI) stake by 43% in Q3 2026, buying an estimated $22K and bringing the position to 10,009 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7254.

UBS Group first reported a position in RMTI in Q4 2014 and has held it in 48 quarters since. The position peaked at $556K in Q2 2016. 28 funds tracked by Wall St. Rank hold RMTI as of Q3 2026.

  • UBS Group held 10,009 shares of Rockwell Medical worth $85.5K as of Q3 2026.
  • UBS Group bought 3,008 Rockwell Medical shares in Q3 2026, an estimated $22K.
  • Rockwell Medical made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7254 holding.
  • UBS Group first reported a position in Rockwell Medical in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Rockwell Medical position peaked at $556K in Q2 2016.
  • 28 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.